RELVAR ELLIPTA 92/22MCG- Relvar Ellipta is indicated for the regular treatment of asthma in adults and adolescents aged 12 years and older and Relvar Ellipta is indicated for the symptomatic treatment of adults with COPD
Learn More£34.50
RELVAR ELLIPTA 184/22MCG – Relvar Ellipta is indicated for the regular treatment of asthma in adults and adolescents aged 12 years and older where use of a combination medicinal product (long-acting beta2-agonist and inhaled corticosteroid) is appropriate:
patients not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short acting beta2-agonists.
patients already adequately controlled on both inhaled corticosteroid and long-acting beta2-agonist.
Learn More£44.90
Click one of our contacts below to chat on WhatsApp